Prescription Drug Price Reporting Act

Summary

Prescription Drug Price Reporting Act This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance. HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 21 November 2019

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 21 November 2019

   Introduced

   Introduced in House

   Source: IntroReferral

3. 21 November 2019

   Introduced

   Introduced in House

   Source: IntroReferral

4. 22 November 2019

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 21 November 2019 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 21 November 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 21 November 2019

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 21 November 2019

  Open at official source

Sponsors

• David Joyce · R · Sponsor
• Anthony Gonzalez · R · Cosponsor
• · hsif00 · Standing

Related records

• related to → Prescription Drug Price Reporting Act